Skip to main content
. 2022 Nov 17;9(2):e002154. doi: 10.1136/openhrt-2022-002154

Table 1.

Descriptive characteristics for the Tromsø Study (Tromsø6) and the Birkebeiner Ageing Study (BiAS) study participants

Baseline characteristics Tromsø6 (n=1867) BiAS (n=505) P value
Age (years) 70 (67–75) 68 (66–71) <0.001
Height (cm) 174.5 (170.1–178.8) 178.0 (175.0–182.0) <0.001
Weight (kg) 81.2 (73.4–89.9) 75.0 (70.0–80.0) <0.001
BMI (kg/m2) 26.8 (24.4–29.1) 23.5 (22.2–24.8) <0.001
Number of Birkebeiner races completed 14 (7–27)
Number of achieved Birkebeiner medals 6 (0–21)
Total years of systematic endurance training 36 (19.0–49.0)
% (n) % (n)
Education <0.001
 Primary/Secondary school 35.6 (646) 16.6 (83)
 High school 35.8 (649) 42.2 (211)
 College/University 28.6 (518) 41.2 (206)
Smoking status <0.001
 Current 15.4 (281) 0.8 (4)
 Former 60.6 (1103) 37.9 (191)
 Never 24.0 (436) 61.3 (309)
Frequency of alcohol consumption <0.001
 Never 14.2 (259) 9.4 (46)
 1–4 times per month 64.1 (1169) 73.0 (356)
 2–3 times a week 15.6 (284) 14.6 (71)
 4 times or more per week 6.2 (113) 3.1 (15)
 Coronary heart disease 24.3 (444) 3.6 (18) <0.001
 Diabetes 8.5 (154) 0.8 (4) <0.001
 Currently or previously on antihypertensive medication 40.5 (729) 15.7 (76) <0.001
Self-reported physical activity <0.001
 Sedentary 19.4 (314) 0.2 (1)
 Light 58.0 (941) 9.8 (48)
 Moderate 21.9 (355) 51.0 (251)
 Vigorous 0.7 (12) 39.0 (192)
 ≥1 AF risk factor present 86.0 (1605) 35.1 (177) <0.001

Values are presented as median (25th and 75th percentile) for continuous variables and as percentages for categorical variables. AF risk factor variable: one or more of the following: BMI ≥25 kg/m2, current smoker, current use of antihypertensive medication, diabetes and coronary heart disease.

AF, atrial fibrillation; BMI, body mass index.